anti-HGF monoclonal antibody YYB101
Term · Oncology and biomedicine · MLC-T-ONC-010783
A humanized monoclonal antibody directed against human hepatocyte growth factor (HGF), with potential antineoplastic activity. Upon administration, anti-HGF monoclonal antibody YYB101 targets and binds to HGF, preventing the binding of HGF to the HGF receptor c-Met and the activation of the c-Met signaling pathway. This may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.
| Identifier | MLC-T-ONC-010783 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-hepatocyte growth factor monoclonal antibody YYB101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010783",
"term": "anti-HGF monoclonal antibody YYB101",
"field": "Oncology and biomedicine",
"definition": "A humanized monoclonal antibody directed against human hepatocyte growth factor (HGF), with potential antineoplastic activity. Upon administration, anti-HGF monoclonal antibody YYB101 targets and binds to HGF, preventing the binding of HGF to the HGF receptor c-Met and the activation of the c-Met signaling pathway. This may result in cell death in c-Met-expressing tumor cells. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis.",
"synonyms": [
"anti-hepatocyte growth factor monoclonal antibody YYB101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-hgf-monoclonal-antibody-yyb101/"
}
Record 1,892 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.